Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. L 688,786
2. L 688786
3. L-688,786
4. L-688786
5. Pneumocandin B(0)
6. Pneumocandin B0
7. Pneumocardin B(0)
1. Pneumocandin B0
2. 135575-42-7
3. Chembl269311
4. N-[(3s,6s,9s,11r,15s,18s,20r,21r,24s,25s)-3-[(1r)-3-amino-1-hydroxy-3-oxopropyl]-6-[(1s,2s)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-15-[(1r)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide
5. L-688786
6. L-688,786
7. Hydroxy Echinocandin
8. Schembl8444763
9. Ex-a1768
10. Bdbm50043897
11. Mfcd28168025
12. Ft-0697597
13. 575p427
14. J-006720
15. J-523985
16. (2r,6s,9s,11r,12r,14as,15s,20s,23s,25as)-20-[2-carbamoyl-1(r)-hydroxyethyl]-23-[1(s),2(s)-dihydroxy-2-(4-hydroxyphenyl)ethyl]-9-(10,12-dimethyltetradecanamido)-2,11,12,15-tetrahydroxy-6-[1(r)-hydroxyethyl]perhydrodipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacycloheneicosine-5,8,14,19,22,25-hexaone
17. (3s)-(4r,5r)-n2-[(10r,12s)-10,12-dimethyl-1-oxotetradecyl]- 4,5-dihydroxy-l-ornithyl-l-threonyl-(4r)-4-hydroxy-l-prolyl-(4s)-4-hydroxy-4-(4-hydroxyphenyl)-l-threonyl-(3r)-3-hydroxy-l-glutaminyl-3-hydroxy-l-proline (6->1)-lactam
18. 10,12-dimethyl-tetradecanoic Acid [3-(2-carbamoyl-1-hydroxy-ethyl)-6-[1,2-dihydroxy-2-(4-hydroxy-phenyl)-ethyl]-11,20,21,25-tetrahydroxy-15-(1-hydroxy-ethyl)-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaaza-tricyclo[22.3.0.0*9,13*]heptacos-18-yl]-amide
19. 1n-[20-(2-carbamoyl-1-hydroxyethyl)-23-[1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,12,15-tetrahydroxy-6-(1-hydroxyethyl)-5,8,14,19,22,25-hexaoxoperhydrodipyrrolo[2,1-c:2,1-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl]-10,12-dimethyltetradecanam
20. N-[[(1r)-3-amino-1-hydroxy-3-oxo-propyl]-[(1s,2s)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-tetrahydroxy-[(1r)-1-hydroxyethyl]-hexaoxo-[?]yl]-10,12-dimethyl-tetradecanamide
| Molecular Weight | 1065.2 g/mol |
|---|---|
| Molecular Formula | C50H80N8O17 |
| XLogP3 | 0.5 |
| Hydrogen Bond Donor Count | 15 |
| Hydrogen Bond Acceptor Count | 17 |
| Rotatable Bond Count | 20 |
| Exact Mass | 1064.56414311 g/mol |
| Monoisotopic Mass | 1064.56414311 g/mol |
| Topological Polar Surface Area | 411 Ų |
| Heavy Atom Count | 75 |
| Formal Charge | 0 |
| Complexity | 1930 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 14 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
61
PharmaCompass offers a list of Hydroxy Echinocandin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hydroxy Echinocandin manufacturer or Hydroxy Echinocandin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hydroxy Echinocandin manufacturer or Hydroxy Echinocandin supplier.
PharmaCompass also assists you with knowing the Hydroxy Echinocandin API Price utilized in the formulation of products. Hydroxy Echinocandin API Price is not always fixed or binding as the Hydroxy Echinocandin Price is obtained through a variety of data sources. The Hydroxy Echinocandin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A L 688786 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L 688786, including repackagers and relabelers. The FDA regulates L 688786 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L 688786 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L 688786 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L 688786 supplier is an individual or a company that provides L 688786 active pharmaceutical ingredient (API) or L 688786 finished formulations upon request. The L 688786 suppliers may include L 688786 API manufacturers, exporters, distributors and traders.
click here to find a list of L 688786 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A L 688786 DMF (Drug Master File) is a document detailing the whole manufacturing process of L 688786 active pharmaceutical ingredient (API) in detail. Different forms of L 688786 DMFs exist exist since differing nations have different regulations, such as L 688786 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A L 688786 DMF submitted to regulatory agencies in the US is known as a USDMF. L 688786 USDMF includes data on L 688786's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The L 688786 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of L 688786 suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing L 688786 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for L 688786 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture L 688786 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain L 688786 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a L 688786 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of L 688786 suppliers with NDC on PharmaCompass.
L 688786 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L 688786 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L 688786 GMP manufacturer or L 688786 GMP API supplier for your needs.
A L 688786 CoA (Certificate of Analysis) is a formal document that attests to L 688786's compliance with L 688786 specifications and serves as a tool for batch-level quality control.
L 688786 CoA mostly includes findings from lab analyses of a specific batch. For each L 688786 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L 688786 may be tested according to a variety of international standards, such as European Pharmacopoeia (L 688786 EP), L 688786 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L 688786 USP).